3..Drug Specifications Promu1gated by the Ministry of Pub1ic Hea1th.P R China.Part 2,Vo1 5,Appendix（卫生部药品标准二部第五[S].,1996.110.. 被引量：1
4Norimats M, Morrison DC. Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli-inoculated mouse whole blood ex vivo[J]. J Infect Dis, 1998,177:1302-1307. 被引量：1
5ucklin SE, Morrison DC. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negativc sepsis[J]. J Infect Dis, 1995, 172:1519-1527. 被引量：1
6Takahashi K, Fukada M, Kawai M, et al. Delection of LPS and identification of its serotype by ELISA using poly-L-Lysine[J].J Immunol Methods, 1992; 153 : 67-71. 被引量：1
7Sabine GZ,Stephan yon H,Aidan PB,et al. Pathophysiologic quantities of endotoxin - induced tumor necrosis factor - alpha release in whole blood from patients with chronic heart failure[J]. Am J Cardiol,2002,90(12) : 1226 - 1230. 被引量：1
8Rennie MJ, Bowtell JL, Brace M, et al. Interaction between glutamine availability and metabolism of glycogen, tricarboxylic acid cycle intermediates and glutathione [ J]. J Nutr,2001,131(9 Suppl) :2488S - 2490S. 被引量：1
9Khogali SE, Pringle SD, Weryk BV, et al. Is glutamine beneficial in ischemic heart disease [J]. Nutrition, 2002, 18(2) :123- 126. 被引量：1
10Khogali SE, Harper AA, Lyall JA, et al. Effects of L- gluta mine on post - ischaemic cardiac function: protection and rescue [J]. J Mol Cell Cardiol, 1998,30(4),819-827. 被引量：1
